Skip to content

Gitr [CAL8] ACI3221A

by Biocare Medical, LLC

Ref ACI3221A

Gitr [CAL8] ACI3221A is a tumour necrosis factor receptor superfamily IVD (EU IVDD general IVD; FDA Class I; FDA product code NJT, Immunohistochemistry Reagents And Kits) made by Biocare Medical, LLC, registered in EUDAMED on 26 Aug 2026 (Basic UDI-DI B-00847627013958) and listed in FDA GUDID since 13 Dec 2022 (UDI-DI 00847627013958), active as of 23 Oct 2026.

Active European Union. Also listed in GUDID (US).

CE IVDD

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, GUDID, synced 23 Oct 2026.

Regulatory status

as of registry sync 23 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD EUDAMED NumberB-00847627013958 Basic UDI-DI 00847627013958UDI-DIDate26 Aug 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number00847627013958 UDI-DI Date13 Dec 2022ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • EUDAMED Basic UDI-DI B-00847627013958 registered 26 Aug 2026 Active
  • FDA GUDID UDI-DI 00847627013958 listed 13 Dec 2022 Listed

Timeline

2 dated events

  1. Listed FDA GUDID 00847627013958
  2. Registered EUDAMED B-00847627013958

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Active
  • United States GUDID listing Listed

Specification

EUDAMED · GUDID

Trade name
Gitr [CAL8]
Generic name
Tumour necrosis factor receptor superfamily IVD, antibody
Model / reference
ACI3221A
Primary DI / UDI-DI
00847627013958
Basic UDI-DI
B-00847627013958
FDA product code
NJT
EMDN code
W01029099 Immunochemistry reagents - other
GMDN term
Tumour necrosis factor receptor superfamily IVD, antibody
Device class
Class IVD General EUDAMED
Class I GUDID
Regulation number
864.1860
EU registration type
Legacy device (under a directive)
EU market of registration
Türkiye
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class IVD General
GUDID
Class I

Device class is stated on each registry's own scale: Class IVD General in the EU (EUDAMED), Class I in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under IMMUNOCHEMISTRY REAGENTS - OTHER.

Other devices from Biocare Medical, LLC

See all devices from Biocare Medical, LLC →

Properties

  • Contains animal tissues or cells
  • Reagent
  • Professional testing
  • Premarket exempt
  • Lot / batch number
  • Expiration date
Other properties (19, all answered No)